anmelden
SPI
18.649,27
PKT
+170,67
PKT
+0,92
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.10.12 | Schindler hold | Vontobel Research | |
| 22.10.12 | Nestlé neutral | Credit Suisse Group | |
| 22.10.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 22.10.12 | Sonova neutral | Sarasin Research | |
| 22.10.12 | Adecco SA neutral | UBS AG | |
| 22.10.12 | Nestlé halten | Independent Research GmbH | |
| 22.10.12 | Nestlé overweight | Morgan Stanley | |
| 22.10.12 | ALSO hold | Vontobel Research | |
| 22.10.12 | OC Oerlikon buy | Vontobel Research | |
| 22.10.12 | EFG International neutral | Sarasin Research | |
| 22.10.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 22.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 19.10.12 | Holcim hold | Deutsche Bank AG | |
| 19.10.12 | Zurich Insurance neutral | Sarasin Research | |
| 19.10.12 | Holcim hold | Deutsche Bank AG | |
| 19.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 19.10.12 | Zurich Insurance hold | Deutsche Bank AG | |
| 19.10.12 | Arbonia buy | UBS AG | |
| 19.10.12 | Nestlé outperform | Exane-BNP Paribas SA | |
| 19.10.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 19.10.12 | Swiss Re neutral | Sarasin Research | |
| 19.10.12 | ABB (Asea Brown Boveri) neutral | Nomura | |
| 19.10.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 19.10.12 | Holcim overweight | J.P. Morgan Cazenove | |
| 19.10.12 | Nestlé hold | Vontobel Research | |
| 19.10.12 | Swiss Re buy | Vontobel Research | |
| 18.10.12 | BB Biotech halten | Independent Research GmbH | |
| 18.10.12 | Roche outperform | Credit Suisse Group | |
| 18.10.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 18.10.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 18.10.12 | UBS overweight | Morgan Stanley | |
| 18.10.12 | UBS equal-weight | Morgan Stanley | |
| 18.10.12 | Julius Bär equal-weight | Morgan Stanley | |
| 18.10.12 | Swiss Life buy | Nomura | |
| 18.10.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 18.10.12 | Roche overweight | J.P. Morgan Cazenove | |
| 18.10.12 | Nestlé buy | Sarasin Research | |
| 18.10.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 18.10.12 | UBS buy | Deutsche Bank AG | |
| 18.10.12 | UBS hold | Deutsche Bank AG |